HUTCHMED (China) Ltd (H7T1 STU) stock market data APIs
€13.3151
0.31(2.3%)
as of July 10, 2025
Try our APIs with
free plan!
HUTCHMED (China) Ltd Financial Data Overview
Price chart is built with
Anychart
Prev. Close
13.3151
Open
13.6227
High
13.6227
Low
13.3151
52 wk Range
10.4-19.5
Market Cap
5 172 M
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get HUTCHMED (China) Ltd data using free add-ons & libraries
Get HUTCHMED (China) Ltd Fundamental Data
HUTCHMED (China) Ltd Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
HUTCHMED (China) Ltd News
New
HUTCHMED Completes Patient Enrollment of a Phase II Registration Study of Savolitinib in Gastric Cancer in China
HUTCHMED (China) Limited HONG KONG and FLORHAM PARK, N.J., April 22, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has com...
HUTCHMED Announces NMPA Conditional Approval for TAZVERIK® (tazemetostat) for the Treatment of Relapsed or Refractory Follicular Lymphoma
HUTCHMED (China) Limited — First and only EZH2 inhibitor approved by the NMPA — — HUTCHMED’s fourth product, and its first approval in hematological malignancies — HONG KONG and SHANGHA...
HUTCHMED (China) Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag
HUTCHMED (China) (LON:HCM) Full Year 2024 Results Key Financial Results Revenue: US$630.2m (down 25% from FY 2023). Net income: US$37.7m (down 63% from FY 2023). Profit margin: 6.0% (down from 12% i...
Intended Retirement of Independent Non-executive Directors and changes of composition of board committees
HUTCHMED (China) Limited HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 20, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED” or the “Company”) (Nasdaq/AIM:HCM, HKEX:1...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
